Quantcast
Last updated on April 16, 2014 at 17:13 EDT

Latest NxStage Medical Inc. Stories

2013-07-01 08:26:33

LAWRENCE, Mass., July 1, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the second quarter ended June 30, 2013, on Thursday, July 25, 2013 before the opening of the financial markets. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) NxStage will also host a conference call at 9:00 a.m. Eastern Time on Thursday, July 25, 2013 to discuss its...

2013-06-26 08:31:17

LAWRENCE, Mass., June 26, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Matthew W. Towse has been appointed Senior Vice President and Chief Financial Officer, and Robert S. Brown, former Senior Vice President and Chief Financial Officer, has been named President of NxStage Kidney Care, Inc., the subsidiary responsible for NxStage's Centers of Excellence initiative. In addition, Kevin Hershberger,...

2013-06-21 08:24:54

LAWRENCE, Mass., June 21, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jay W. Shreiner has been appointed to its Board of Directors effective immediately. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Most recently, Mr. Shreiner served as Interim Chief Financial Officer for Behavioral Centers of America from April 2012 until its acquisition by Acadia Healthcare in December...

2013-05-21 16:28:03

Agreements Cover Supply of NxStage's Innovative Product Technology across Home, Critical Care and In-Center Markets Through 2015 LAWRENCE, Mass., May 21, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it has entered into new agreements covering its supply of home, critical care and in-center products to DaVita, the kidney care division of DaVita Healthcare Partners Inc. (Logo:...

2013-05-09 08:30:40

LAWRENCE, Mass., May 9, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the following schedule of investor conferences.  A webcast of the event will be made available at http://ir.nxstage.com/ at the time of each conference.   (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) William Blair 33(rd) Annual...

2013-05-02 08:37:09

Highlights: LAWRENCE, Mass., May 2, 2013 /PRNewswire/ -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported first quarter financial results with revenue at the upper end of its guidance range. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Revenue for the first quarter of 2013 increased 8% to $61.6 million, compared with revenue of $57.0 million for the first quarter of 2012. The higher...

2013-04-30 08:34:17

Product provides patients with benefits of home hemodialysis and greater treatment flexibility based on their clinical and lifestyle needs LAWRENCE, Mass., April 30, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that the U.S. Food and Drug Administration (FDA) has cleared new high flow capabilities with the NxStage System One(TM), the only truly portable hemodialysis system cleared for home...

2013-04-25 16:31:04

LAWRENCE, Mass., April 25, 2013 /PRNewswire/ -- NxStage Medical, Inc.(®) (NASDAQ: NXTM) announced today that Robert G. Funari has been appointed as the non-executive Chairman of the Board effective immediately. Mr. Funari is the former Chairman of Crescent Healthcare and has served on the NxStage Board of Directors since January 2013. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Mr. Funari succeeds Dr. Philippe Chambon, who resigned after having served on the...

2013-04-09 08:29:49

LAWRENCE, Mass., April 9, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the first quarter ended March 31, 2013, on Thursday, May 2, 2013 before the opening of the financial markets. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) NxStage will also host a conference call at 9:00 a.m. Eastern Time on Thursday, May 2, 2013 to discuss its first...

2013-04-08 08:30:16

Company to Leverage Recent CE Mark Approvals for System One Innovations LAWRENCE, Mass., April 8, 2013 /PRNewswire/ -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, announced today that it has completed its move to a direct sales model in the United Kingdom. NxStage will begin selling the System One(TM) and related products and services directly in the region through its wholly-owned UK subsidiary, NxStage Medical UK, Ltd. The...